{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:54:31Z","timestamp":1783720471157,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.028","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T01:17:25Z","timestamp":1606785445000},"page":"412-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A cost-effectiveness analysis of South Africa\u2019s seasonal influenza vaccination programme"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-3092","authenticated-orcid":false,"given":"Ijeoma","family":"Edoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Kohli-Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7100-571X","authenticated-orcid":false,"given":"Heather","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-347X","authenticated-orcid":false,"given":"Stefano","family":"Tempia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-4033","authenticated-orcid":false,"given":"Meredith","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Ramkrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-8899","authenticated-orcid":false,"given":"Philipp","family":"Lambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-5065","authenticated-orcid":false,"given":"Raymond","family":"Hutubessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-2302","authenticated-orcid":false,"given":"Cheryl","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.vaccine.2020.11.028_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.11.028_b0010","article-title":"Influenza NICD Recommendations for the diagnosis, prevention, management and public health response","author":"Blumberg","year":"2017","journal-title":"National Institute for Communicable Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0015","first-page":"325","article-title":"Global burden of influenza: contributions from resource limited and low-income settings","volume":"9","author":"Fischer","year":"2014","journal-title":"Global heart"},{"key":"10.1016\/j.vaccine.2020.11.028_b0020","unstructured":"Massyn, N., et al., District Health Barometer 2015\/16 2016, Health Systems Trust: Durban."},{"key":"10.1016\/j.vaccine.2020.11.028_b0025","unstructured":"Statistics South Africa, Mortality and causes of death in South Africa, 2015: Findings from death notification. 2017: Pretoria."},{"issue":"9","key":"10.1016\/j.vaccine.2020.11.028_b0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/cid\/ciu095","article-title":"Mortality Associated With Seasonal and Pandemic Influenza and Respiratory Syncytial Virus Among Children <5 Years of Age in a High HIV Prevalence Setting\u2014South Africa, 1998\u20132009","volume":"58","author":"Tempia","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.028_b0035","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/civ448","article-title":"Mortality Associated With Seasonal and Pandemic Influenza Among Pregnant and Nonpregnant Women of Childbearing Age in a High-HIV-Prevalence Setting\u2014South Africa, 1999\u20132009","volume":"61","author":"Tempia","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/irv.12650","article-title":"Health and economic burden of influenza-associated illness in South Africa, 2013\u20132015","volume":"13","author":"Tempia","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.028_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117716","article-title":"Epidemiology of Severe Acute Respiratory Illness (SARI) among Adults and Children Aged \u22655 Years in a High HIV-Prevalence Setting, 2009\u20132012","volume":"10","author":"Cohen","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2020.11.028_b0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza Vaccination of Pregnant Women and Protection of Their Infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hivar.2016.04.002","article-title":"How successful is influenza vaccination in HIV infected patients? Results from an influenza A(H1N1)pdm09 vaccine study","volume":"15","author":"Schwarze-Zander","year":"2016","journal-title":"HIV & AIDS Review"},{"key":"10.1016\/j.vaccine.2020.11.028_b0060","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.vaccine.2020.11.028_b0065","doi-asserted-by":"crossref","unstructured":"Jefferson, T., et al., Vaccines for preventing influenza in healthy children. The Cochrane database of systematic reviews, 2018. 2: p. CD004879.","DOI":"10.1002\/14651858.CD004879.pub5"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vaccine.2018.11.048","article-title":"Prioritization of risk groups for influenza vaccination in resource limited settings \u2013 A case study from South Africa","volume":"37","author":"McMorrow","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.028_b0075","unstructured":"National Department of Health, National Influenza Policy and Strategic Plan 2017 to 2021, National Department of Health, Editor. 2017."},{"key":"10.1016\/j.vaccine.2020.11.028_b0080","unstructured":"National Department of Health, Influenza Vaccinations: Post Vaccination Evaluation 2018, National Department of Health: Communicable Diseases."},{"issue":"4","key":"10.1016\/j.vaccine.2020.11.028_b0085","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4161\/hv.23637","article-title":"Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies","volume":"9","author":"Jit","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"46","key":"10.1016\/j.vaccine.2020.11.028_b0090","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally \u2013 A review","volume":"31","author":"Peasah","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vaccine.2010.08.078","article-title":"The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales","volume":"29","author":"Jit","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0100","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/649013","article-title":"Economic Value of Seasonal and Pandemic Influenza Vaccination during Pregnancy","volume":"49","author":"Beigi","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6, Supplement","key":"10.1016\/j.vaccine.2020.11.028_b0105","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.ajog.2011.04.009","article-title":"Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy","volume":"204","author":"Myers","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0110","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.vaccine.2014.01.017","article-title":"The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required","volume":"32","author":"Newall","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amepre.2006.03.008","article-title":"Influenza Vaccination: Health Impact and Cost Effectiveness Among Adults Aged 50 to 64 and 65 and Older","volume":"31","author":"Maciosek","year":"2006","journal-title":"Am J Prev Med"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM199409223311206","article-title":"The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community","volume":"331","author":"Nichol","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.ajkd.2010.12.016","article-title":"Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients","volume":"57","author":"Lee","year":"2011","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/j.ajkd.2011.02.380","article-title":"Nothing to Sneeze At: Efficacy and Cost-Effectiveness of the Influenza Vaccine in Patients Receiving Long-term Dialysis","volume":"57","author":"Abbott","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027059","article-title":"The Cost-Effectiveness and Value of Information of Three Influenza Vaccination Dosing Strategies for Individuals with Human Immunodeficiency Virus","volume":"6","author":"Nosyk","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.028_b0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jhm.286","article-title":"Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma","volume":"3","author":"Teufel","year":"2008","journal-title":"Journal of Hospital Medicine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amepre.2010.07.012","article-title":"The Economic Implications of Influenza Vaccination for Adults with Asthma","volume":"39","author":"Trogdon","year":"2010","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.028_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vhri.2019.03.001","article-title":"Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa","volume":"19","author":"Alshreef","year":"2019","journal-title":"Value in Health Regional Issues"},{"issue":"46","key":"10.1016\/j.vaccine.2020.11.028_b0160","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1016\/j.vaccine.2019.09.059","article-title":"A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa","volume":"37","author":"Biggerstaff","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.028_b0165","first-page":"997","article-title":"The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa","volume":"36","author":"de Boer","year":"2018","journal-title":"Vietnam and Australia. Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2020.11.028_b0170","first-page":"461","volume":"87","year":"2012","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2020.11.028_b0175","unstructured":"World Health Organization. Influenza economics: Economic guidance. 2019 [cited 2019; Available from: https:\/\/www.who.int\/immunization\/research\/development\/influenza_economics\/en\/."},{"key":"10.1016\/j.vaccine.2020.11.028_b0180","series-title":"Influenza Vaccinations: Post Vaccination Evaluation","author":"National Department of Health","year":"2017"},{"key":"10.1016\/j.vaccine.2020.11.028_b0185","unstructured":"World Health Organization. Global Health Observatory data repository, Life tables by country: South Africa. 2017 [cited 2019 18 September 2019]; Available from: https:\/\/apps.who.int\/gho\/data\/?theme=main&vid=61540."},{"key":"10.1016\/j.vaccine.2020.11.028_b0190","unstructured":"Department of Health, Guidelines for Pharmacoeconomic Submissions 2012, Health, Editor. 2013, Government Gazette."},{"issue":"27","key":"10.1016\/j.vaccine.2020.11.028_b0195","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.vaccine.2020.04.045","article-title":"Influenza Disease Burden among Potential Target Risk Groups for Immunization in South Africa, 2013\u20132015","volume":"38","author":"Tempia","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.11.028_b0200","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/cid\/ciy1017","article-title":"Quantifying How Different Clinical Presentations, Levels of Severity, and Healthcare Attendance Shape the Burden of Influenza-associated Illness: A Modeling Study From South Africa","volume":"69","author":"Tempia","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.028_b0205","series-title":"Global Epidemiological Surveillance Standards for Influenza","author":"World Health Organization","year":"2014"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/irv.12529","article-title":"The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013\u20132015","volume":"12","author":"Tempia","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0215","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal Influenza Infections and Cardiovascular Disease Mortality","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiology"},{"issue":"21","key":"10.1016\/j.vaccine.2020.11.028_b0225","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case\u2013control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.vaccine.2020.11.028_b0230","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226108","article-title":"Severe capillary leak syndrome with cardiac arrest triggered by influenza virus infection","volume":"2018","author":"Ebdrup","year":"2018","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.vaccine.2020.11.028_b0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijcard.2018.02.028","article-title":"Extreme influenza epidemics and out-of-hospital cardiac arrest","volume":"263","author":"Onozuka","year":"2018","journal-title":"Int J Cardiol"},{"issue":"14","key":"10.1016\/j.vaccine.2020.11.028_b0240","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2020.11.028_b0245","doi-asserted-by":"crossref","first-page":"E342","DOI":"10.1503\/cmaj.151059","article-title":"Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes","volume":"188","author":"Vamos","year":"2016","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4037\/ajcc2018901","article-title":"Outcomes of Acute Kidney Injury in Patients With Severe ARDS Due to Influenza A(H1N1) pdm09 Virus","volume":"27","author":"Tignanelli","year":"2018","journal-title":"Am J Crit Care"},{"issue":"11","key":"10.1016\/j.vaccine.2020.11.028_b0255","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7883\/yoken.JJID.2018.494","article-title":"Acute Liver Failure Associated with Influenza A Virus Infection: an Autopsy Case Report","volume":"72","author":"Nonaka","year":"2019","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2020.11.028_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103736","article-title":"Influenza A virus infection induces liver injury in mice","volume":"137","author":"Zhang","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2020.11.028_b0270","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0275","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-11-170","article-title":"Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007\u20132008","volume":"11","author":"Fielding","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.11.028_b0280","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210124","article-title":"Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women","volume":"13","author":"Nunes","year":"2019","journal-title":"PLoS ONE"},{"issue":"9461","key":"10.1016\/j.vaccine.2020.11.028_b0290","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(05)17984-7","article-title":"Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review","volume":"365","author":"Jefferson","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.11.028_b0295","unstructured":"McMorrow, M., Meta-analysis output for vaccine efficacy in children 6-23 months. 2019: Unpublished update to Jefferson 2018 meta-analysis. ."},{"issue":"49","key":"10.1016\/j.vaccine.2020.11.028_b0300","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1016\/j.vaccine.2011.08.008","article-title":"A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups","volume":"29","author":"Michiels","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060477","article-title":"Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1)2009 Patients","volume":"8","author":"Hollmann","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.11.028_b0310","unstructured":"World Health Organization. Global Health Observatory data repository: Life tables by country. 2017 [cited 2018 18 Jan 2018]; Available from: http:\/\/apps.who.int\/gho\/data\/view.main.61540?lang=en."},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-1-11","article-title":"How do Zimbabweans value health states?","volume":"1","author":"Jelsma","year":"2003","journal-title":"Population Health Metrics"},{"issue":"4","key":"10.1016\/j.vaccine.2020.11.028_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001418","article-title":"Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies","volume":"10","author":"Johnson","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.11.028_b0325","unstructured":"Fraser, H., et al., Cost of Seasonal Influenza Vaccination Programme in South Africa. unpublished manuscript: Unpublished manuscript."},{"key":"10.1016\/j.vaccine.2020.11.028_b0330","doi-asserted-by":"crossref","unstructured":"Tempia, S., et al., Influenza Economic Burden among Potential Target Risk Groups for Immunization in South Africa, 2013-2015. 2020: Under review by Vaccine.","DOI":"10.1016\/j.vaccine.2020.09.033"},{"issue":"11","key":"10.1016\/j.vaccine.2020.11.028_b0335","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3201\/eid1911.130546","article-title":"Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009\u20132011","volume":"19","author":"Cohen","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.028_b0340","unstructured":"World Health Organization, Information sheet: Observed rate of vaccine reactions, influenza vaccine. 2012."},{"issue":"9047","key":"10.1016\/j.vaccine.2020.11.028_b0345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.11.028_b0350","unstructured":"National Department of Health. Uniform Patient Fee Schedule. 2018 [cited 2019 15 August 2019]; Available from: http:\/\/www.health.gov.za\/index.php\/shortcodes\/2015-03-29-10-42-47\/2015-04-30-09-10-23\/uniform-patient-fee-schedule\/category\/448-upfs-2018#."},{"key":"10.1016\/j.vaccine.2020.11.028_b0355","unstructured":"South African Reserve Bank. Selected historical rates: Rand per US Dollar. 2018 [cited 2020 12 September 2020]; Available from: https:\/\/www.resbank.co.za\/Research\/Rates\/Pages\/SelectedHistoricalExchangeAndInterestRates.aspx."},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.028_b0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Effectiveness and Resource Allocation"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.028_b0365","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","article-title":"Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies","volume":"21","author":"Leech","year":"2018","journal-title":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.028_b0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2020.11.028_b0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40273-014-0162-x","article-title":"Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines","volume":"32","author":"Newall","year":"2014","journal-title":"PharmacoEconomics"},{"issue":"12","key":"10.1016\/j.vaccine.2020.11.028_b0380","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"14","key":"10.1016\/j.vaccine.2020.11.028_b0385","doi-asserted-by":"crossref","DOI":"10.3310\/hta19140","article-title":"Methods for the Estimation of the NICE Cost Effectiveness Threshold","volume":"19","author":"Claxton","year":"2015","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.028_b0390","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40273-017-0585-2","article-title":"Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System","volume":"36","author":"Edney","year":"2018","journal-title":"PharmacoEconomics"},{"issue":"4","key":"10.1016\/j.vaccine.2020.11.028_b0395","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hec.3633","article-title":"Estimating a cost-effectiveness threshold for the Spanish NHS","volume":"27","author":"Vallejo-Torres","year":"2018","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.vaccine.2020.11.028_b0400","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Global Health"},{"issue":"8","key":"10.1016\/j.vaccine.2020.11.028_b0405","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research","volume":"19","author":"Woods","year":"2016","journal-title":"Value in Health"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.028_b0410","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/heapol\/czz152","article-title":"Estimating a cost-effectiveness threshold for health care decision-making in South Africa","volume":"35","author":"Edoka","year":"2020","journal-title":"Health Policy and Planning"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.028_b0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.vaccine.2020.11.028_b0420","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1467-9868.2004.05304.x","article-title":"Probabilistic sensitivity analysis of complex models: a Bayesian approach","volume":"66","author":"Oakley","year":"2004","journal-title":"Journal of the Royal Statistical Society: Series B (Statistical Methodology)"},{"issue":"44","key":"10.1016\/j.vaccine.2020.11.028_b0425","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1016\/j.vaccine.2009.08.004","article-title":"The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa","volume":"27","author":"Sinanovic","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.028_b0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2018.05.024","article-title":"Cost-effectiveness analysis of universal influenza vaccination: Application of the susceptible\u2013infectious\u2013complication\u2013recovery model","volume":"73","author":"Yang","year":"2018","journal-title":"International Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2020.11.028_b0435","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF03404197","article-title":"An Incremental Economic Evaluation of Targeted and Universal Influenza Vaccination in Pregnant Women","volume":"102","author":"Skedgel","year":"2011","journal-title":"Can J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:31Z","timestamp":1759402291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20314687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20314687"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cost-effectiveness analysis of South Africa\u2019s seasonal influenza vaccination programme","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}